Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres von Samaan, Mark A, Pavlidis, Polychronis, Johnston, Emma, Warner, Ben, Digby-Bell, Jonathan, Koumoutsos, Ioannis, Fong, Steven, Goldberg, Rimma, Patel, Kamal, Gulati, Shraddha, Medcalf, Lucy, Sastrillo, Marlene, Brown-Clarke, Cordella, Bidewell-Sullivan, Johanna, Forsyth, Katrina, Lee, Emma, Stanton, Anna, Duncan, Julie, Chung-Faye, Guy, Dubois, Patrick, Powell, Nick, Anderson, Simon, Sanderson, Jeremy, Hayee, Bu'Hussain, Irving, Peter M

Volltext

Su1101 Indeterminate and Inconclusive Results Are Common When Using Interferon Gamma Release Assay As Screening for TB in Patients With IBD von Nasr, Ikram, Goel, Rishi M, Ward, Mark G, Fong, Steven C, Patel, Kamal V, Ray, Shuvra, Sastrillo, Marlene, Anderson, Simon H, Sanderson, Jeremy D, Irving, Peter M

Volltext

Cost Analysis of Screening According to ECCO Guidelines for Prevention of Opportunistic Infections in Infliximab-Treated IBD Patients von Metz, Andrew J, Elliott, Tim, Hull, Bradley, Duncan, Julie, Sastrillo, Marlene, Smith, Melissa A, Sanderson, Jeremy D, Irving, Peter M

Volltext